Replies to post #467846 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

No need for checkmate. Case closed.

[Basin Street Blues]

Odious

[hope4patients]

Good to see you’re enjoying your Sunday, Ex. By!

[The Danish Dude]

That would be as absurd as saying all checkpoint inhibiitors are Keyttruda because Keytruda is a CI.

So lets keep it to the basics.

1) Keytruda is always Pembrolizumab

2) ATL-DC is a class, an autologous dendritic cell vaccine

3) The UCLA Spore 1 project is the equivalent of the combo clinical GBM trial Pembrolizumab with ATL-DC. Both with two control arms of 20 patients in each

4) A sh__load of sources, several from UCLA including Linda Liau in presentations, have confirmed ATL-DC in said combo trial to be DCVax-L, latest Timothy Cloughesy two days ago.

Thats all there is to it, whether you like it or not.